The assay was first validated using healthy adult blood challenged with a broad array of immune stimuli and subsequently applied to analyze inducible blood responses in children with systemic juvenile idiopathic arthritis (sJIA), a rare and severe IL-1–driven autoinflammatory disease of unknown etiology (Gurion et al., 2012). Here, IL1B is linked to systemic-onset juvenile idiopathic arthritis.